PTI
Proteostasis Therapeutics, Inc.
Cormorant Asset Management, LLC bought $4.1M of Proteostasis Therapeutics, Inc.
10% owner
Bought$4,124,945
$11.40Price
361,863Shares
+12%Stake
What PTI did for a copier
Prices for PTI after this filing aren't in yet.
Cormorant Asset Management, LLC's record
17 other buys with 3 months of prices since 2016: on average −6.0% against the S&P 500, and 8 of 17 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Nov 21. Filed Wed, Nov 23, 12:24 PM ET, during the session. Not investment advice.